New Bacteriophages with Podoviridal Morphotypes Active against Yersinia pestis: Characterization and Application Potential

Viruses. 2023 Jun 30;15(7):1484. doi: 10.3390/v15071484.

Abstract

Phages of highly pathogenic bacteria represent an area of growing interest for bacterial detection and identification and subspecies typing, as well as for phage therapy and environmental decontamination. Eight new phages-YpEc56, YpEc56D, YpEc57, YpEe58, YpEc1, YpEc2, YpEc11, and YpYeO9-expressing lytic activity towards Yersinia pestis revealed a virion morphology consistent with the Podoviridae morphotype. These phages lyse all 68 strains from 2 different sets of Y. pestis isolates, thus limiting their potential application for subtyping of Y. pestis strains but making them rather promising in terms of infection control. Two phages-YpYeO9 and YpEc11-were selected for detailed studies based on their source of isolation and lytic cross activity towards other Enterobacteriaceae. The full genome sequencing demonstrated the virulent nature of new phages. Phage YpYeO9 was identified as a member of the Teseptimavirus genus and YpEc11 was identified as a member of the Helsettvirus genus, thereby representing new species. A bacterial challenge assay in liquid microcosm with a YpYeO9/YpEc11 phage mixture showed elimination of Y. pestis EV76 during 4 h at a P/B ratio of 1000:1. These results, in combination with high lysis stability results of phages in liquid culture, the low frequency of formation of phage resistant mutants, and their viability under different physical-chemical factors indicate their potential for their practical use as an antibacterial mean.

Keywords: bacteriophage; phage genome; phage therapy; phage typing; plague.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents
  • Bacteriophages*
  • Podoviridae* / genetics
  • Yersinia pestis* / genetics

Substances

  • Anti-Bacterial Agents

Grants and funding

This work was conducted within the frame of the grant project STCU P486 “Application of bacteriophages against highly pathogenic bacteria in model studies”. Funding was provided by the Directorate General for International Relations and Strategy (DGRIS) with the scientific support of IRBA (French Armed Forces Biomedical Research Institute) within the framework of the French MoD’s involvement in the G7 Global partnership. The French Agency for International Technical Expertise (AFETI) ensured the project’s financial execution and contributed to the implementation of the cooperation actions under the control of the DHRIS.